Upcoming Login Downtime
We're updating the Biocentury.com platform login experience to make access more secure and reliable. As part of this update, logins will be temporarily unavailable on Sunday, March 16, from 4:00AM to 4:00PM GMT. We recognize the inconvenience and appreciate your understanding. Please check back after the maintenance period.
For updates, questions, or issues, please call us at +1 650-552-4224 or email us at support@biocentury.com.
- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a company name.
3t Biosciences Inc.
Headquarters: South San Francisco, CA, United States of America
Website: https://3tbiosciences.com/
Year Founded: 2017
Status: Private
BioCentury | Mar 5, 2025
Management Tracks
CFO Anthony Doyle resigns at Biocryst
Plus: Greenside succeeds CEO Mark DePristo at Bighat, and updates from Be Biopharma, 3t and Imugene
BioCentury | Jan 4, 2024
Deals
Pair of Novo deals within Flagship framework among many ahead of JPM
Early 2024 dealmaking activity also included Roche-MOMA, Avenzo-Allorion, AbbVie-Umoja and Boehringer-3T
BioCentury | Oct 25, 2023
Management Tracks
Korro promoting Chappell to COO, adding Pearson to board
Plus: 3T hires Irving and updates from Q32 Bio, Garuda and Fibrocor
BioCentury | Jan 10, 2023
Deals
Jan. 9 Deals Quick Takes: Lilly adds trio of Treg programs in TRex Bio deal
Plus: Boehringer, 3T partner to discover new TCR targets and updates from Immunocore, Ionis-Royalty, Kronos, Genentech, ATP’s Aethon
BioCentury | Aug 25, 2022
Emerging Company Profile
3T Biosciences: making TCR-based therapies more tumor selective
Start-up debuts with $40M in Westlake-led A round to translate TCR discovery platform into bispecifics pipeline
BioCentury | May 21, 2020
Emerging Company Profile
Repertoire bets on both sides of the TCR-antigen coin
Led by John Cox, Repertoire is mapping how TCRs, peptide-MHC complexes relate to each other, and to disease
BioCentury | Aug 22, 2019
Emerging Company Profile
Tscan: Tracking down novel T cell targets
Tscan is finding novel TCR-antigen pairs with its peptidome screening platform
Items per page:
1 - 7 of 7